HCA Healthcare, Inc.: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Feb 23, 2018 and accepted by EDGAR at Feb 23, 2018, 16:41 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 12 months2017-01-01 to 2017-12-31 | $1.69bn | us-gaap:InterestExpense |
| Income tax | 12 months2017-01-01 to 2017-12-31 | $1.64bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-10-01 to 2017-12-31 | $474.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2017-01-01 to 2017-12-31 | $2.22bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-10-01 to 2017-12-31 | $1.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | $5.95 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-10-01 to 2017-12-31 | $1.34 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2017-01-01 to 2017-12-31 | $6.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-01-01 to 2017-12-31 | 372,221,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $3.02bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2017-01-01 to 2017-12-31 | $2.05bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $732.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $9.98bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $36.59bn | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $6.16bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $41.59bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-12-31 | $32.86bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-12-31 | $200.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-12-31 | −$6.81bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-18-056057. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.